Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes
This qualitative study (n=7) interviewed Swiss therapists about psychedelic-assisted therapy and found they saw psychedelics as working alongside psychotherapy rather than replacing it. Therapists described a synergy that could strengthen trust, depth and meaningful therapeutic experiences within long-term treatment.
Authors
- Helena Aicher
Published
Abstract
Research on the therapeutic effects of psychedelics in psychiatry, commonly referred to as Psychedelic-Assisted Therapy (PAT), has expanded substantially in recent years. The context-dependent nature of psychedelics has sparked discussion about the importance of the psychotherapeutic environment in achieving beneficial outcomes. This study explores the contribution of psychotherapeutic factors on PAT in Switzerland, where psychedelic treatments can be implemented within long-term clinical frameworks. Seven semi-structured interviews were conducted with Swiss therapists to explore how they frame psychedelic treatments and the role of the psychotherapeutic setting in facilitating therapeutic outcomes. Thereby, individual experiences of the patients as reported by the therapists, were particularly considered. Thematic analysis identified two main themes, each with several sub-themes. The first theme revealed that while psychotherapeutic techniques are adapted to PAT, they retain similarities to non-psychedelic psychotherapy practices, supporting patients in having meaningful therapeutic experiences. The second theme describes a synergistic relationship between psychedelics and psychotherapy, amplifying underlying general psychotherapeutic factors such as trust, a sense of profundity, and the emergence of therapeutic experiences. The interviewed therapists agreed that psychedelics work as unspecific catalysts for psychotherapeutic processes, while still acknowledging the potential for psychopharmacological effects or the interaction between psychedelics and psychotherapy to create unique psychotherapeutic processes. Findings from our sample suggest that, for specific indications, incorporating psychedelics into long-term psychotherapeutic treatment may strengthen therapeutic processes. Future research could investigate the efficacy of PAT within the framework of specific psychotherapeutic modalities or in different settings, including prospective quantitative assessments of outcomes. Ultimately, clarifying mechanisms of action of PAT may help to enhance its efficacy and potentially to integrate psychedelic treatments into mainstream mental health care.
Research Summary of 'Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes'
Blossom's Take
Psychedelic-assisted therapy has been allowed in Switzerland for many decades. This proves to be a great place to investigate to see the real-world (not in clinical trials) implementation of this therapeutic model. Unlike arguments put forth by drug developers (e.g. Compass), the therapists argue for a strong shaping by the psychotherapeutic process (vs only the drug effect).
Introduction
Interest in psychedelic-assisted therapy (PAT) has increased sharply over the past decade, with previous studies suggesting benefits for conditions such as depression, post-traumatic stress disorder, addiction, anxiety, and end-of-life distress. At the same time, there is an unresolved debate about how much of PAT’s effect comes from the psychedelic substance itself and how much comes from the psychotherapeutic context in which it is delivered. The paper situates this discussion within the idea that psychedelics are highly context-dependent and that “set and setting”, preparation, and post-session integration may be central to outcomes. It also notes that current research often gives limited attention to the therapeutic framework, even though patients in clinical and some research settings commonly receive psychological support from trained therapists. Stellmacher and colleagues therefore set out to explore how psychotherapy contributes to PAT in Switzerland, where psychedelic treatments can be delivered in long-term clinical frameworks outside formal trials. Rather than asking whether psychotherapy matters, the study asks how and why psychotherapeutic processes shape PAT, and how they interact with the psychedelic experience. The authors framed the inquiry around three possible relationships between psychedelics and psychotherapy: a mainly psychopharmacological view, a catalyst view in which psychedelics amplify psychotherapeutic processes, and the possibility that PAT constitutes a distinct class of psychotherapeutic process. The study was designed as a qualitative interview study of Swiss therapists practising PAT. This focus is particularly relevant because Swiss clinical practice allows psychedelic sessions to be integrated over extended periods into ongoing psychotherapy, offering a setting that differs from the shorter, more standardised support structures often used in trials.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Author
- APA Citation
Stellmacher, J., Schmidt, C., Aicher, H. D., Eichel, K., Brakemeier, E. L., & Herwig, U. (2026). Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1771726
References (35)
Papers cited by this study that are also in Blossom
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)
Reiff, C. M., Richman, E. E., Nemeroff, C. B. et al. · American Journal of Psychiatry (2020)
Luoma, J. B., Chwyl, C., Bathje, G. J. et al. · Journal of Psychoactive Drugs (2020)
Calder, A. E., Hasler, G. · Neuropsychopharmacology (2022)
Goodwin, G. M., Malievskaia, E., Fonzo, G. A. et al. · American Journal of Psychiatry (2023)
Gründer, G., Brand, M., Mertens, L. J. et al. · Lancet Psychiatry (2024)
Brennan, C., Kelman, A., Belser, A. B. · Psyarxiv (2023)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Wolff, M., Evens, R., Mertens, L. J. et al. · Frontiers in Psychiatry (2020)
Mertens, L. J., Koslowski, M., Betzler, F. et al. · Neuroscience Applied (2022)
Show all 35 referencesShow fewer
Hieronymus, F., López, E., Sjögren, H. W. et al. · JAMA Network Open (2025)
Mueller, F., Hawrot, T., Schmid, Y. · Neuroscience Applied (2025)
Carhart-Harris, R. L., Bolstridge, &. M., Day, C. M. J. et al. · Psychopharmacology (2017)
Goodwin, G. M., Aaronson, S. T., Alvarez, O. et al. · New England Journal of Medicine (2022)
Aday, J. S., Horton, D. M., Fernandes-Osterhold, G. et al. · Psychopharmacology (2024)
Murphy, R., Murphy-Beiner, A., Kettner, H. et al. · Frontiers in Pharmacology (2022)
Vargas, M. V., Dunlap, L. E., Dong, C. et al. · Science (2023)
Passie, T., Guss, J., Kraehenmann, R. · Frontiers in Psychiatry (2022)
Yehuda, R., Lepow, L., Morishita, H. · Frontiers in Neuroscience (2021)
Neil, J. C., Nutt, D. J. · Journal of Psychopharmacology (2022)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Earp, B. D., Repantis, D., Langlitz, N. et al. · Frontiers in Psychiatry (2021)
Olson, D. E. · ACS Pharmacology and Translational Science (2020)
Cavarra, M., Falzone, A., Ramaekers, J. G. et al. · Frontiers in Psychology (2022)
Yaden, D. B., Earp, D., Graziosi, M. et al. · Frontiers in Psychology (2022)
Watts, R., Luoma, J. B. · Journal of Contextual Behavioral Science (2020)
McGovern, H., Grimmer, H. J., Doss, M. K. et al. · Communications Psychology (2024)
Bøhling, F. · International Journal of Drug Policy (2017)
Gandy, S., Forstmann, M., Carhart-Harris, R. L. et al. · Health Psychology Open (2020)
O'callaghan, C., Hubik, D. J., Psychiatry, M. et al. · Journal of Music Therapy (2020)
Back, A., Myers, S., Guy, J. et al. · Psychedelic Medicine (2024)
Smith, W. R., Sisti, D. · Journal of Medical Ethics (2020)
Luoma, J. B., Allen, L. R., Gold, V. et al. · Psychedelic Medicine (2024)
Phelps, J. · Journal of Humanistic Psychology (2017)
Hartogsohn, I. · Journal of Psychopharmacology (2016)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.